Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |